. Author manuscript; available in PMC: 2021 Sep 1.

Published in final edited form as: Aliment Pharmacol Ther. 2020 Aug 8;52(6):976–987. doi: 10.1111/apt.16013

TABLE 1.

Participants’characteristics at baseline, the ASMIC study

Participant characteristics at baseline	Aspirin N = 30	Placebo N = 20	P-value^a
Age, Mean (SD) y	62.2 (5.1)	61.2 (5.2)	0.74
Gender, Female; n (%)	23 (76.7%)	9 (45.0%)	0.19
BMI, Mean (SD), kg/m²	27.3 (4.3)	28.2 (4.8)	0.74
Urinary PGE-M^b (adjusted for creatinine) Mean (SD) y	11.82 (13.59)	12.94 (7.39)	0.74

P-value were adjusted for multiple inference using the PROC MULTTEST function based on the raw P-values for the continuous variable and the Yates corrected p-value for the categorical P-value.

PGE-M - metabolite of prostaglandin E2.